Invention Grant
- Patent Title: Antipsychotic treatment based on SNP genotype
- Patent Title (中): 基于SNP基因型的抗精神病药物治疗
-
Application No.: US15085778Application Date: 2016-03-30
-
Publication No.: US09458507B1Publication Date: 2016-10-04
- Inventor: Christian Lavedan , Simona Volpi , Louis Licamele , Mihael H. Polymeropoulos
- Applicant: Vanda Pharmaceuticals, Inc.
- Applicant Address: US DC Washington
- Assignee: Vanda Pharmaceuticals, Inc.
- Current Assignee: Vanda Pharmaceuticals, Inc.
- Current Assignee Address: US DC Washington
- Agency: Hoffman Warnick LLC
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; A61K31/454
Abstract:
The present invention relates to the prediction of antipsychotic treatment efficacy based on a patient's genotype at one or more single nucleotide polymorphism (SNP) loci and to the treatment of a patient based on such prediction.
Public/Granted literature
- US20160265060A1 ANTIPSYCHOTIC TREATMENT BASED ON SNP GENOTYPE Public/Granted day:2016-09-15
Information query
